Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Global

iShares Global Healthcare ETF

+ Add to Watchlist

IXJ:AU

139.7900 AUD 1.9500 1.38%

As of 01:58:35 ET on 04/28/2015.

Snapshot for iShares Global Healthcare ETF (IXJ)

Open: 140.9100 High - Low: 140.9100 - 139.5000 Primary Exchange: ASE
Volume: 12,193 52-Week Range: 96.8000 - 146.2200 Beta vs SGHNW: 0.8684

ETF Chart for IXJ

No chart data available.
  • IXJ:AU 139.7900
  • 1D
  • 1M
  • 1Y
141.7400
Interactive IXJ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IXJ

iShares Global Healthcare ETF is an exchange-traded fund incorporated in the USA. The ETF tracks the S&P Global Healthcare Index. The ETF holds global large- cap health care stocks. Its investments are focused in pharmaceutical, biotech, and medical device companies, with its largest allocation to the United States. A market capitalization methodology is used for weighting.

Inception Date: 2009-03-12 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / DIANE HSIUNG
Web Site: www.ishares.com

Fundamentals for IXJ

NAV -
Assets (M) (on 2015-04-27) 1,675.5300
Shares out (M) 9.15
Market Cap (M) 1,279.08
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for IXJ

Dividend Type Income
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-22) 0.3858
Dividend Yield (ttm) 1.09%

Performance for IXJ

1-Month +2.19% 1-Year +47.04%
3-Month +7.53% 3-Year +37.07%
Year To Date +15.31% 5-Year +22.36%
Expense Ratio 0.48

Top Fund Holdings for IXJ

Filing Date: 04/24/2015
Name Position Value % of Total
Novartis AG 1,053,165 110,306,834 6.538%
Johnson & Johnson 1,082,140 109,382,711 6.483%
Pfizer Inc 2,385,100 84,122,477 4.986%
Roche Holding AG 273,585 79,418,178 4.707%
Merck & Co Inc 1,104,405 63,613,728 3.770%
Gilead Sciences Inc 578,890 60,027,999 3.558%
Amgen Inc 295,240 49,573,748 2.938%
Sanofi 467,870 48,731,798 2.888%
Bayer AG 321,470 47,259,385 2.801%
Actavis plc 151,586 44,780,020 2.654%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil